Lin Shen
Author
Institutions Peking University, Peking University Cancer Hospital
Past institutions Peking University, Peking University Cancer Hospital, Qilu Hospital of Shandong University, Central South University, Xiangya Hospital Central South University +5 more
ORCID: Yes
H-index: 48
I10-index: 149
Works count: 488
Citations count: 12,710
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
2021 · Jong‐Mu Sun, Lin Shen, et al. · The Lancet
3D printing of conducting polymers
2020 · Hyunwoo Yuk, Baoyang Lu, et al. · Nature Communications
The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer
2019 · Feng‐Hua Wang, Lin Shen, et al. · Cancer Communications